Clinical Trials Arena on MSN
ASH 2025: MSD’s B-ALL drug shows potential, but all patients experience AEs
MSD will now look to uncover the optimal dose of MK-1045 to guide future studies on the drug.
Now that we know why raw sewage sometimes backs up into basements and overflows in public waterways, why hasn’t it been fixed yet? Backed Up examines the first possible villain in this mystery: a ...
AMERICAN drugmaker MSD on Wednesday (Oct 5) announced the opening of two manufacturing facilities to produce vaccines and biologics in Singapore. The new factories are part of the US$500 million ...
LOUISVILLE, Ky. (WDRB) -- As the Ohio River rises around Louisville, MSD crews are working around the clock to prevent flooding. Some roads in Louisville have been closed due to flooding after heavy ...
Let's face it, many problem areas in custom trucks don't rear their ugly heads until the manufacturer has already built hundreds of thousand of trucks and SUVs. For instance, Ford's Coil on Plug (CoP) ...
MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results